Track Medpace Holdings, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Medpace Holdings, Inc. MEDP · Stock Open Medpace Holdings, Inc. in new tab

653.39 USD
P/E
36.94
EPS
18.01
P/B
31.81
ROE
117.88
Beta
1.11
Target Price
651.31 USD
Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

🧾 Earnings Recap – Q3 2025

Medpace reported a strong Q3 2025 with revenue of $659.9 million, up 23.7% year-over-year, driven by record net bookings and solid backlog growth.

  • Net new business awards surged 47.9% year-over-year to $789.6 million, resulting in a net book-to-bill ratio of 1.20.
  • Ending backlog rose to approximately $3 billion, reflecting a 2.5% increase year-over-year, with $1.84 billion expected to convert to revenue in the next 12 months.
  • Q3 EBITDA climbed 24.9% to $148.4 million, with an EBITDA margin of 22.5%, supported by productivity gains despite higher reimbursable costs.
  • Updated 2025 total revenue guidance set at $2.48 billion to $2.53 billion, indicating growth of 17.6% to 20% over 2024.
  • Year-to-date cash flow from operations reached $246.2 million, and the company repurchased 2.96 million shares, reinforcing commitment to returning value to shareholders.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 8, 2027
P/E36.94
EPS18.01
Book Value20.92
Price to Book31.81
Debt/Equity29.31
% Insiders18.662%
Growth
Revenue Growth0.09%
Earnings Growth0.25%
Estimates
Forward P/E33.51
Forward EPS19.85
Target Mean Price651.31

DCF valuation

Model fair value for Medpace Holdings, Inc. (MEDP)
Result
Sign in to run the valuation for MEDP.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
13 analysts · consensus None · mean target 651.31 USD (low 370.00, high 730.00) · as of 11 Nov 2026
Low 370.00
Mean 651.31
High 730.00
Price 653.39
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Medpace Holdings, Inc. Logo Medpace Holdings, Inc. Analysis (MEDP)

United States Health Care Official Website Stock

Is Medpace Holdings, Inc. a good investment? Medpace Holdings, Inc. (MEDP) is currently trading at 653.39 USD. Market analysts have a consensus price target of 651.31 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 36.94. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Medpace Holdings, Inc. is expected to release its next earnings report on Feb. 8, 2027. The market consensus estimate for Forward EPS is 19.85.

Investor FAQ

Does Medpace Holdings, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Medpace Holdings, Inc.?

Medpace Holdings, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 8, 2027. The company currently has a trailing EPS of 18.01.

Company Profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Exchange Ticker
NMS (United States) MEDP
FRA (Germany) 01P.F
MEX (Mexico) MEDP.MX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion